Biopharmaceutical Development Service by LGC

Manufacturer LGC  |  Available Worldwide
  |  1 reviews
To meet the specific challenges of biopharmaceutical development, we have a team of scientists with expertise in immuochemistry and cell based approaches for this important class of therapeutic agent.

Biopharmaceutical Development Service by LGC product image
Biopharmaceutical Development Service
Request Pricing


Receive your quote directly from the manufacturer.

Average Rating: 5.0
1 Scientist has reviewed this product

5 out of 5
Ease of use
5 out of 5
After sales service
5 out of 5
Value for money

Rating: 5.0

  • Application Area: PK and IG analysis in human matrices

"Quality, communication, punctuality and flexibility were all excellent."

Review date: 18 Nov 2016 | Biopharmaceutical Development Service

Our capabilities and experience cover recombinant proteins, vaccines, blood products, monoclonal antibodies, oligonucleotides, gene therapy products and more.

Development and validation of bioanalytical assays to support your biopharmaceutical development programme, whether it be Pharmacokinetic (PK), Anti-Drug-Antibody (ADA), Neutralising Antibodies (nAbs) or Pharmacodynamic (PD) is core to our business.

Our bioanalytical services for biopharmaceuticals include:

  • New method development
  • Method validation (GLP, GCP or non-regulated)
  • Sample analysis to support discovery, preclinical and clinical programmes
  • Macromolecule quantification and characterisation to support biopharmaceutical development and manufacture.

Experienced, qualified staff and investment in the latest technologies allow us to provide high quality bioanalytical services for biopharmaceuticals in support of all stages of your development.